AU8096094A - Use of nicotine substitutes for the treatment of nicotine withdrawal - Google Patents
Use of nicotine substitutes for the treatment of nicotine withdrawalInfo
- Publication number
- AU8096094A AU8096094A AU80960/94A AU8096094A AU8096094A AU 8096094 A AU8096094 A AU 8096094A AU 80960/94 A AU80960/94 A AU 80960/94A AU 8096094 A AU8096094 A AU 8096094A AU 8096094 A AU8096094 A AU 8096094A
- Authority
- AU
- Australia
- Prior art keywords
- nicotine
- treatment
- substitutes
- withdrawal
- nicotine withdrawal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Addiction (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14430993A | 1993-10-28 | 1993-10-28 | |
US144309 | 1993-10-28 | ||
US08/145,203 US5414005A (en) | 1993-10-28 | 1993-10-28 | Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation |
US145203 | 1993-10-28 | ||
PCT/US1994/012441 WO1995011678A1 (en) | 1993-10-28 | 1994-10-28 | Use of nicotine substitutes for the treatment of nicotine withdrawal |
Publications (1)
Publication Number | Publication Date |
---|---|
AU8096094A true AU8096094A (en) | 1995-05-22 |
Family
ID=26841884
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU80960/94A Abandoned AU8096094A (en) | 1993-10-28 | 1994-10-28 | Use of nicotine substitutes for the treatment of nicotine withdrawal |
AU10456/95A Abandoned AU1045695A (en) | 1993-10-28 | 1994-10-28 | Use of lobeline for the treatment of nicotine withdrawal |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU10456/95A Abandoned AU1045695A (en) | 1993-10-28 | 1994-10-28 | Use of lobeline for the treatment of nicotine withdrawal |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0725640A1 (zh) |
JP (1) | JPH09507053A (zh) |
AU (2) | AU8096094A (zh) |
CA (1) | CA2174747A1 (zh) |
TW (1) | TW261531B (zh) |
WO (2) | WO1995011679A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE326468T1 (de) * | 1996-10-30 | 2006-06-15 | Pfizer | Pyridon-kondensierte azabicyclische- oder cytisin-derivate, ihre herstellung und verwendung in der suchttherapie |
ES2141024B1 (es) * | 1997-10-03 | 2000-10-16 | Manzanares Jesus Mari Gonzalez | Preparado de accion antinicotinica. |
GB2376884A (en) * | 2001-06-26 | 2002-12-31 | Peter Hajek | Helping smokers stop |
WO2005044139A2 (en) * | 2003-10-28 | 2005-05-19 | Alza Corporation | Method and apparatus for reducing the incidence of tobacco use |
CN103284319A (zh) * | 2013-06-20 | 2013-09-11 | 昌宁德康生物科技有限公司 | 一种金雀花碱替代尼古丁口腔雾化液及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1017032A (en) * | 1963-12-12 | 1966-01-12 | Aerosmoke Ltd | Aerosol compositions |
GB1056214A (en) * | 1964-05-21 | 1967-01-25 | Leo Baum | Compositions containing lobeline sulphate |
JPS59500217A (ja) * | 1982-02-22 | 1984-02-16 | ベロルススキ− ナウチノ− イスレドワ−チエルスキ− サニタルノ− ギギエニチエスキ− インスチツ−ト | 抗ニコチン効果を有する製剤およびその製造法 |
US4665069A (en) * | 1985-04-02 | 1987-05-12 | Barnett Rosenberg | Analgesic composition and method of relieving pain |
GB2230439A (en) * | 1989-04-20 | 1990-10-24 | Alec Stanley Walter Shaw | Nicotine lozenges |
-
1993
- 1993-11-08 TW TW082109338A patent/TW261531B/zh active
-
1994
- 1994-10-28 WO PCT/US1994/012442 patent/WO1995011679A1/en not_active Application Discontinuation
- 1994-10-28 EP EP95901081A patent/EP0725640A1/en not_active Withdrawn
- 1994-10-28 CA CA002174747A patent/CA2174747A1/en not_active Abandoned
- 1994-10-28 WO PCT/US1994/012441 patent/WO1995011678A1/en active Application Filing
- 1994-10-28 JP JP7512876A patent/JPH09507053A/ja not_active Ceased
- 1994-10-28 AU AU80960/94A patent/AU8096094A/en not_active Abandoned
- 1994-10-28 AU AU10456/95A patent/AU1045695A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1995011679A1 (en) | 1995-05-04 |
AU1045695A (en) | 1995-05-22 |
JPH09507053A (ja) | 1997-07-15 |
TW261531B (zh) | 1995-11-01 |
CA2174747A1 (en) | 1995-05-04 |
EP0725640A1 (en) | 1996-08-14 |
WO1995011678A1 (en) | 1995-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7545594A (en) | Implantable device for the treatment of aedemas | |
GB2265297B (en) | Sterilisation process in the manufacture of snuff | |
AU7567394A (en) | Treatment chamber catheter | |
AU4525396A (en) | Process for the preparation of perfluorocarbons | |
AU7205894A (en) | Purified natural and synthetic compounds for the treatment of osteoarthritis | |
AU7931194A (en) | Apparatus for treatment of the oral cavity | |
AU3375693A (en) | Method of the treatment of dry nose syndrome | |
AU1115095A (en) | Treatment of cellulose | |
AU3268893A (en) | New tobacco substitutes | |
EP0510503A3 (en) | Process for the treatment of surfaces | |
IL114128A0 (en) | Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms | |
AU5581594A (en) | Cigarette and process for preparing the cigarette | |
AU2387097A (en) | Substituted benzylamines and their use for the treatment of depression | |
AU4090289A (en) | Method for the treatment of wool | |
AU7310896A (en) | Use of nitroflavonoids for the treatment of anxiety | |
AU1116895A (en) | Use of theophylline for the manufacture of a medicament for the treatment of asthma | |
AU2806692A (en) | Medicament for the treatment of anxiety | |
EP0674707A4 (en) | COMPOUNDS AND METHODS FOR THE TREATMENT OF LEUCOMA. | |
AU1279788A (en) | Compounds and treatment | |
IL114129A0 (en) | Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms | |
AU6927894A (en) | 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions | |
AU8096094A (en) | Use of nicotine substitutes for the treatment of nicotine withdrawal | |
AU3028492A (en) | Process for the manufacture of 2-alkoxymethylacrolein | |
AU4812393A (en) | Use of rapamycin in the treatment of aids | |
IL114130A0 (en) | Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms |